John Roderick ten Bosch, an officer at BillionToOne, Inc., has filed a notice to sell 2,834 shares of the company's Class A stock. The shares are valued at approximately $320,724 based on the current market price. This transaction is part of a series of stock sales by ten Bosch over the past few months, reflecting ongoing management of his equity holdings.

This filing is significant as it highlights the activity of executives in the medical laboratories sector, where transparency in stock transactions is crucial for maintaining investor trust. The filing was made on November 2, 2026, and is part of a broader trend of executive stock management within the industry.

Background

BillionToOne, Inc. operates in the medical laboratories sector, specifically focusing on innovative testing solutions. The company is incorporated in Delaware and has its business address in Menlo Park, California. The latest filing is part of a series of recent disclosures, including various transactions by ten Bosch, who has been actively managing his stock holdings.

What the Filing Says

The SEC filing indicates that ten Bosch sold the shares on November 2, 2026. It states, "The number of units sold is 2,834, with an aggregate market value of $320,723.78." This transaction follows several other sales made by ten Bosch in recent months, indicating a consistent pattern of selling shares.

Impact

This transaction may affect shareholders and potential investors in BillionToOne, Inc. as it reflects the actions of company executives in managing their stock. The transparency of such transactions is essential for maintaining investor confidence and ensuring compliance with SEC regulations.

What's Next

The filing does not say what happens next.